Tumor necrosis factor-alpha expression in ischemic neurons.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Stroke

• Publication date

  1994-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.25.7.1481PMID 8023366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of TNFα and IL-1a immunoreactivities in striatal neurons after surgical injury to the hippocampus

  1993cited by this paper
• Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage.

  1993cited by this paper
• Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus.

  1993cited by this paper
• Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study.

  1993cited by this paper
• Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model.

  1993cited by this paper
• Interleukin-1 beta mRNA expression in ischemic rat cortex.

  1993cited by this paper
• Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells.

  1993cited by this paper
• Genetic hypertension and increased susceptibility to cerebral ischemia.

  1992cited by this paper
• Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury.

  1992cited by this paper
• Tumor necrosis factor-alpha gene expression in the tissues of normal mice.

  1992cited by this paper
• Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat.

  1992cited by this paper
• Inhibition of Polymorphonuclear Leukocyte Adherence Suppresses No‐Reflow After Focal Cerebral Ischemia in Baboons

  1992cited by this paper
• In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis.

  1992cited by this paper
• Release of Proinflammatory and Prothrombotic Mediators in the Brain and Peripheral Circulation in Spontaneously Hypertensive and Normotensive Wistar‐Kyoto Rats

  1992cited by this paper
• Rat tumor necrosis factor-alpha. Transcription in rat Kupffer cells and in vitro posttranslational processing based on a PCR-derived cDNA.

  1992cited by this paper
• Reperfusion Increases Neutrophils and Leukotriene B4 Receptor Binding in Rat Focal Ischemia

  1992cited by this paper
• Cytokine regulation of endothelial cell function

  1992cited by this paper
• Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets.

  1992cited by this paper
• Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury

  1992cited by this paper
• Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta.

  1992cited by this paper
• Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.

  1992cited by this paper
• Tumor necrosis factor induces genes involved in inflammation, cellular and tissue repair, and metabolism in murine fibroblasts.

  1992cited by this paper
• Cytokine regulation of endothelial cell function.

  1992cited by this paper
• Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.

  1991cited by this paper
• Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain.

  1991cited by this paper
• The role of neutrophils and platelets in a rabbit model of thromboembolic stroke.

  1991cited by this paper
• HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease

  1991cited by this paper
• Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke.

  1991cited by this paper
• Neutrophil as a mediator of ischemic edema formation in the brain.

  1991cited by this paper
• The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms.

  1991cited by this paper
• Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

  1991cited by this paper
• Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

  1991cited by this paper
• Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification

  1991cited by this paper
• Tumor necrosis factor alpha selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation.

  1991cited by this paper
• Elevated alpha–tumor necrosis factor levels in spinal fluid from HIV‐1–infected patients with central nervous system involvement

  1991cited by this paper
• Tumor necrosis factor Characterization at the molecular, cellular and in vivo level

  1991cited by this paper
• Increase in omega 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide.

  1991cited by this paper
• Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brain

  1991cited by this paper
• Effects of neutrophil depletion and superoxide dismutase on postischemic hypoperfusion of rat brain.

  1990cited by this paper
• Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.

  1990cited by this paper
• Cytokines and endothelial cell biology.

  1990cited by this paper
• Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2]

  1990cited by this paper
• Interleukins and tumor necrosis factor in inflammation.

  1990cited by this paper
• Leukocyte involvement in cerebral ischemia and reperfusion injury.

  1990cited by this paper
• Tumor necrosis factor identified in multiple sclerosis brain

  1989cited by this paper
• Influence of granulocytopenia on canine cerebral ischemia induced by air embolism.

  1989cited by this paper
• On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases

  1989cited by this paper
• Delayed Hypoperfusion after Incomplete Forebrain Ischemia in the Rat. The Role of Polymorphonuclear Leukocytes

  1989cited by this paper
• Rodent models of cerebral ischemia.

  1989cited by this paper
• Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

  1989cited by this paper
• Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus.

  1989cited by this paper
• Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response

  1989cited by this paper
• The Quantification of Cerebral Infarction following Focal Ischemia in the Rat: Influence of Strain, Arterial Pressure, Blood Glucose Concentration, and Age

  1988cited by this paper
• Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.

  1988cited by this paper
• Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction.

  1988cited by this paper
• Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

  1988cited by this paper
• Focal Brain Ischemia in the Rat: Methods for Reproducible Neocortical Infarction Using Tandem Occlusion of the Distal Middle Cerebral and Ipsilateral Common Carotid Arteries

  1988cited by this paper
• Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes.

  1987cited by this paper
• Tumor necrosis factors: gene structure and biological activities.

  1986cited by this paper
• Modulation of endothelial cell hemostatic properties by tumor necrosis factor

  1986cited by this paper
• Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells.

  1986cited by this paper

• Diabetes Mellitus and Malaria Co‐Existence as Deadly Burden in Sub‐Saharan Africa: A Review of Clinical Outcomes and Molecular Interactions

  2026cites this paper
• QUICKI is a Useful Biomarker in Predicting Clinical Outcomes Among Ischemic Stroke Patients Without Type 2 Diabetes Mellitus.

  2026cites this paper
• The Dynamics of Neuroinflammation in Traumatic Brain Injury: Molecular Markers Useful for Establishing the Post-Traumatic Interval in Forensic Practice.

  2026cites this paper
• Review: Systemic inflammation after stroke. Therapy and perspective.

  2026cites this paper
• Serum levels of inflammatory markers, sP-selectin, IL-1β, IL-6, and hsCRP are positively correlated with tissue factor transcript level of peripheral blood mononuclear cells in stroke.

  2025cites this paper
• Advancing Ischemic Stroke Prognosis: Key Role of MiR-155 Non-Coding RNA

  2025cites this paper
• Region-Specific Long-Term Transcriptional Changes in the Plasminogen Activation System and Neuroinflammation in the Rat Brain After Status Epilepticus: Association with Depressive-like Behavior

  2025cites this paper
• Ischemic stroke and inflammatory markers: a case–control study

  2025cites this paper
• Neuroinflammation in kidney disease and dialysis.

  2025cites this paper
• Identification of potential therapeutic targets for stroke using data mining, network analysis, enrichment, and docking analysis

  2025cites this paper
• The Roles of Circular RNAs in Ischemic Stroke through Modulating Neuroinflammation.

  2024cites this paper
• Applications and Mechanisms of Taohong Siwu Decoction in the Treatment of Ischemic Stroke

  2024cites this paper
• Stroke in the Time of Circadian Medicine.

  2024cites this paper
• Molecular Pathogenesis of Ischemic and Hemorrhagic Strokes: Background and Therapeutic Approaches

  2024cites this paper
• Label-Free Three-Dimensional Morphological Characterization of Cell Death Using Holographic Tomography

  2024cites this paper
• mRNA Profiling and Transcriptomics Analysis of Chickens Received Newcastle Disease Virus Genotype II and Genotype VII Vaccines

  2024cites this paper
• The relationship among H2S, neuroinflammation and MMP-9 in BBB injury following ischemic stroke.

  2024cites this paper
• The impact of cytokines in neuroinflammation-mediated stroke.

  2024cites this paper
• Molecular Mechanisms of Ischemic Stroke: A Review Integrating Clinical Imaging and Therapeutic Perspectives

  2024cites this paper
• Melatonin, an Antitumor Necrosis Factor Therapy

  2024cites this paper
• Association of Long Non-Coding RNA Malat1 with Serum Levels of Interleukin-1 Beta and Vitamin D in Patients with Ischemic Stroke

  2023cites this paper
• Comparing the Efficacy of Ozone Therapy and Medical Treatment on Serum Levels of TNF-α and HS-CRP and Improvement of Neurological Symptoms in the Rehabilitation Phase of Patients With Ischemic Stroke

  2023cites this paper
• Central IRF4/5 Signaling Are Critical for Microglial Activation and Impact on Stroke Outcomes

  2023cites this paper
• After Ischemic Stroke, Minocycline Promotes a Protective Response in Neurons via the RNA-Binding Protein HuR, with a Positive Impact on Motor Performance

  2023cites this paper
• Anti-inflammatory effects of yeast-derived vacuoles on LPS-induced murine macrophage activation

  2023cites this paper
• Sustained Hyperammonemia Activates NF-κB in Purkinje Neurons Through Activation of the TrkB-PI3K-AKT Pathway by Microglia-Derived BDNF in a Rat Model of Minimal Hepatic Encephalopathy

  2023cites this paper
• Neuroinflammatory Biomarkers in the Brain, Cerebrospinal Fluid, and Blood After Ischemic Stroke

  2023cites this paper
• Reparative, Neuroprotective and Anti-neurodegenerative Effects of Granulocyte Colony Stimulating Factor in Radiation-Induced Brain Injury Model

  2023cites this paper
• Post‐inflammatory administration of N‐acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease

  2023cites this paper
• Uncovering Mechanism and Efficacy of Salvia Miltiorrhiza-Safflower in Cerebral Ischemia-Reperfusion Injury.

  2023cites this paper
• A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies

  2023cites this paper
• Neural stem cell-derived exosomes-loaded adhesive hydrogel controlled-release promotes cerebral angiogenesis and neurological function in ischemic stroke.

  2023cites this paper
• Calcitonin gene-related peptide: a potential protective agent in cerebral ischemia–reperfusion injury

  2023cites this paper
• Beneficial effects of buspirone in endothelin-1 induced stroke cachexia in rats

  2023cites this paper
• Development of endothelial-targeted CD39 as a therapy for ischaemic stroke

  2023cites this paper
• ERK1/2 Activity Is Critical for the Outcome of Ischemic Stroke

  2022cites this paper
• Elevated Plasma Soluble ST2 Levels are Associated With Neuronal Injury and Neurocognitive Impairment in Children With Cerebral Malaria

  2022cites this paper
• Factors Associated with Elevated Tumor Necrosis Factor-α in Aqueous Humor of Patients with Open-Angle Glaucoma

  2022cites this paper
• β2-Microglobulin exacerbates neuroinflammation, brain damage, and cognitive impairment after stroke in rats

  2022cites this paper
• The role of diphenhydramine HCl on tumor necrosis factor-α levels in wistar rats with traumatic brain injury: An in vivo study

  2022cites this paper
• Characterization of Astrocytes in the Minocycline-Administered Mouse Photothrombotic Ischemic Stroke Model

  2022cites this paper
• Targeting TNFα-mediated cytotoxicity using thalidomide after experimental cardiac arrest in rats: An exploratory study.

  2022cites this paper
• Tumor Necrosis Factor-α: The Next Marker of Stroke

  2022cites this paper
• Effects of systemic inflammation due to hepatic ischemia-reperfusion injury upon lean or obese visceral adipose tissue

  2022cites this paper
• Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model

  2022cites this paper
• Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies

  2021cites this paper
• A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration

  2021cites this paper
• Chandamarutha Chenduram, an Indian traditional siddha preparation attenuated the neuronal degeneration in ischemic mice through ameliorating cytokines and oxy-radicals mediated EAAT-2 dysfunction.

  2021cites this paper
• Estradiol Inhibits Human Brain Vascular Pericyte Migration Activity: A Functional and Transcriptomic Analysis

  2021cites this paper
• Neuroinflammatory Triangle Presenting Novel Pharmacological Targets for Ischemic Brain Injury

  2021cites this paper
• Role of Na+/K+-ATPase in ischemic stroke: in-depth perspectives from physiology to pharmacology

  2021cites this paper
• Role of cellular prion protein in splenic CD4+ T cell differentiation in cerebral ischaemic/reperfusion

  2021cites this paper
• Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease

  2021cites this paper
• Design and characterization of a novel dimeric blood–brain barrier penetrating TNFα inhibitor

  2021cites this paper
• Sensing the world and its dangers: An evolutionary perspective in neuroimmunology

  2021cites this paper
• Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?

  2021cites this paper
• Methylprednisolone Treatment in Brain Death-Induced Lung Inflammation–A Dose Comparative Study in Rats

  2021cites this paper
• β-Cell Function and Clinical Outcome in Nondiabetic Patients With Acute Ischemic Stroke

  2021cites this paper
• Inflammation-Mediated Angiogenesis in Ischemic Stroke

  2021cites this paper
• Exploring potential serum levels of Homocysteine, interleukin‐1 beta, and apolipoprotein B 48 as new biomarkers for patients with ischemic stroke

  2021cites this paper
• microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke

  2020cites this paper
• Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-κB pathway

  2020cites this paper
• Insights into the neuropathology of cerebral ischemia and its mechanisms

  2020cites this paper
• Biotechnology and Bioengineering

  2020cites this paper
• Propionic acid abrogates the deleterious effects of cerebral ischemic reperfusion injury through nuclear factor-κb signaling in mice

  2020cites this paper
• Integrated analysis of the proteome and transcriptome in a MCAO mouse model revealed the molecular landscape during stroke progression

  2020cites this paper
• Modulation of advanced glycation endproducts (AGEs) signaling in experimentally induced stroke in mice.

  2020cites this paper
• Clinical Efficacy of Tonic Traditional Chinese Medicine Injection on Acute Cerebral Infarction: A Bayesian Network Meta-Analysis

  2020cites this paper
• The role of autoimmunity after traumatic brain injury

  2020cites this paper
• ROLES OF TUMOR NECROSIS FACTOR IN ANIMAL TISSUES

  2020cites this paper
• Cellular infiltration in traumatic brain injury

  2020cites this paper
• Neurological Damage by Coronaviruses: A Catastrophe in the Queue!

  2020cites this paper
• Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches

  2020cites this paper
• Changes of Tumor Necrosis Factor- Alpha Gene Expression in Hippocampus of Rats after Brain Stroke and Endurance Training

  2020cites this paper
• G-CSF Attenuates Neuroinflammation and Neuronal Apoptosis via the mTOR/p70SK6 Signaling Pathway in Neonatal Hypoxia-Ischemia Rat Model.

  2020cites this paper
• Prevention or treatment of enzyme treated royal jelly on monosodium-iodoacetate-induced osteoarthritis

  2020cites this paper
• Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia

  2020cites this paper
• miR-148 a regulates inflammation in microglia induced by oxygen-glucose deprivation via MAPK signal pathways

  2019influential citation
• Neuroprotective effect of chlorogenic acid in global cerebral ischemia-reperfusion rat model

  2019cites this paper
• Minocycline fails to improve neurologic and histologic outcome after ventricular fibrillation cardiac arrest in rats

  2019cites this paper
• Gene Therapy for Neuroanesthesia

  2019cites this paper
• Effects of pycnogenol on ischemia/reperfusion-induced inflammatory and oxidative brain injury in rats.

  2019cites this paper
• Micro RNA 181c-5p: a promising target for post-stroke recovery in socially isolated mice.

  2019cites this paper
• Neurovascular Unit as a Source of Ischemic Stroke Biomarkers—Limitations of Experimental Studies and Perspectives for Clinical Application

  2019cites this paper
• Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia‐induced brain injury

  2019cites this paper
• Does Pretreatment with a Tumor Necrosis Factor Alpha-inhibitor Improve the Outcome After Ischemic Cerebral Infarction? A Case Report

  2019cites this paper
• Brain–kidney interaction: Renal dysfunction following ischemic stroke

  2019cites this paper
• N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway

  2019cites this paper
• Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

  2019cites this paper
• Neuroprotective effects of oleic acid in rodent models of cerebral ischaemia

  2019cites this paper
• [Correlations between parameters of central hemodynamics and cytokine profile in chronic kidney disease in combination with cerebrovascular diseases].

  2019cites this paper
• Transient Focal Ischemia Significantly Alters the m6A Epitranscriptomic Tagging of RNAs in the Brain.

  2019cites this paper
• Anti-inflammatory Effects of Traditional Chinese Medicines on Preclinical in vivo Models of Brain Ischemia-Reperfusion-Injury: Prospects for Neuroprotective Drug Discovery and Therapy

  2019cites this paper
• High‐mobility group box‐1 translocation and release after hypoxic ischemic brain injury in neonatal rats

  2019cites this paper
• Multi-modal imaging of long-term recovery post-stroke by positron emission tomography and matrix-assisted laser desorption/ionisation mass spectrometry.

  2018cites this paper
• Ethanol Iris tenuifolia extract reduces brain damage in a mouse model of cerebral ischaemia

  2018cites this paper
• Insulin resistance and clinical outcomes after acute ischemic stroke

  2018cites this paper
• Effectiveness of arginase inhibitors against experimentally induced stroke

  2018cites this paper
• Secretome from SH-SY5Y APPSwe cells trigger time-dependent CHME3 microglia activation phenotypes, ultimately leading to miR-21 exosome shuttling.

  2018cites this paper
• An innovative approach to treatment of chronic migraine, and craniofacial neuralgia

  2018cites this paper